Supernus Pharmaceuticals Inc (SUPN)
30.24
+0.18
(+0.60%)
USD |
NASDAQ |
May 02, 16:00
30.24
0.00 (0.00%)
After-Hours: 18:12
Supernus Pharmaceuticals Cash from Financing (Quarterly): 1.092M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.092M |
| September 30, 2023 | -0.23M |
| June 30, 2023 | -478.92M |
| March 31, 2023 | 80.17M |
| December 31, 2022 | 2.829M |
| September 30, 2022 | 6.455M |
| June 30, 2022 | 2.273M |
| March 31, 2022 | -22.03M |
| December 31, 2021 | -136.74M |
| September 30, 2021 | 1.324M |
| June 30, 2021 | 2.749M |
| March 31, 2021 | 2.247M |
| December 31, 2020 | 3.069M |
| September 30, 2020 | -0.979M |
| June 30, 2020 | 1.437M |
| March 31, 2020 | 0.032M |
| December 31, 2019 | 1.263M |
| September 30, 2019 | 0.242M |
| June 30, 2019 | 1.64M |
| March 31, 2019 | 0.783M |
| December 31, 2018 | 1.251M |
| September 30, 2018 | 0.828M |
| June 30, 2018 | 6.646M |
| March 31, 2018 | 367.71M |
| December 31, 2017 | 1.171M |
| Date | Value |
|---|---|
| September 30, 2017 | 2.346M |
| June 30, 2017 | 1.56M |
| March 31, 2017 | 0.604M |
| December 31, 2016 | 0.797M |
| September 30, 2016 | 0.26M |
| June 30, 2016 | 0.871M |
| March 31, 2016 | 0.124M |
| December 31, 2015 | 0.80M |
| September 30, 2015 | 0.058M |
| June 30, 2015 | 0.862M |
| March 31, 2015 | 0.147M |
| December 31, 2014 | 0.306M |
| September 30, 2014 | 30.01M |
| June 30, 2014 | 0.245M |
| March 31, 2014 | 0.005M |
| December 31, 2013 | -1.454M |
| September 30, 2013 | -0.018M |
| June 30, 2013 | 65.23M |
| March 31, 2013 | -1.021M |
| December 31, 2012 | 42.38M |
| September 30, 2012 | -2.225M |
| June 30, 2012 | 48.82M |
| March 31, 2012 | -1.057M |
| December 31, 2011 | 14.89M |
| September 30, 2011 | -1.317M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-478.92M
Minimum
Jun 2023
80.17M
Maximum
Mar 2023
-28.00M
Average
1.324M
Median
Sep 2021
Cash from Financing (Quarterly) Benchmarks
| Dynavax Technologies Corp | 1.776M |
| Ligand Pharmaceuticals Inc | 5.315M |
| Pacira BioSciences Inc | -1.779M |
| Esperion Therapeutics Inc | 4.471M |
| Collegium Pharmaceutical Inc | -67.83M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 44.96M |
| Cash from Investing (Quarterly) | -65.98M |
| Free Cash Flow | 110.53M |
| Free Cash Flow Per Share (Quarterly) | 0.8136 |
| Free Cash Flow to Equity (Quarterly) | 44.99M |
| Free Cash Flow to Firm (Quarterly) | 44.99M |
| Free Cash Flow Yield | 6.44% |